Coherus BioSciences, Inc. (CHRS) Share-based Payment Arrangement, Expense USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Coherus BioSciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2024.
  • Coherus BioSciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $7.32 M, a 40.4% decline year-over-year.
  • Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $43.1 M, a 15% decline from 2022.
  • Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $50.7 M, a 1.22% decline from 2021.
  • Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $51.4 M, a 34.6% increase from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $7.32 M -$4.96 M -40.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $12.3 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2021 $800 K Feb 1, 2021 Feb 28, 2021 10-K 2024-03-15
Q2 2015 $4.62 M +$3.54 M +329% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $2.18 M +$1.69 M +343% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q2 2014 $1.08 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $491 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.